Kaia Health has raised a further $75m to expand its AI-based treatment for Musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD). The company’s technology is based on motion-capture technology that can be used on an everyday smartphone to give feedback about exercises and physical therapy.… Read More »Kaia Health raises $75m for digital musculoskeletal disease therapy
Kaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care. Founder and CEO Konstantin Mehl spoke to pharmaphorum’s news editor Richard Staines about why these treatments will be in demand… Read More »Kaia Health gets $75m for digital solution to strains and pains of pandemic workplace
What You Should Know: – Digital therapeutics company, Kaia Health, has raised $75M Series C round (total: $125M) to expand clinical capabilities and transform the treatment path for Musculoskeletal (MSK) and Chronic obstructive pulmonary disease (COPD) care in the U.S. and Europe. – The Series C round was led… Read More »Digital Therapeutics Startup Kaia Health Raises $75M to Optimize MSK & COPD Care
Shares in Hikma have rallied as it resumed the launch of its generic Advair Diskus in the US, after clearing up a final piece of bureaucracy with the FDA. The London-listed firm is one of several companies that had been trying to make generics of… Read More »Hikma shares rally after US launch of Advair generic resumes
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West Virginia has decided in favour of AZ in litigation against Mylan Pharmaceuticals and Kindeva, the company… Read More »AstraZeneca breathes sigh of relief as court blocks US Symbicort generic
What You Should Know: – Highmark Health has engaged Verily to build out digital health tools for patients and analytics solutions for Highmark’s clinicians as part of its Living Health model. This marks the first collaboration of its kind for Verily, Google Cloud and a partner. – Highmark Health… Read More »Highmark Health Taps Verily to Build Digital Health Tools for Living Health Model
UK-based Verona Pharma has scored a new win with its chronic obstructive pulmonary disease (COPD) drug ensifenitrine, after a formulation delivered with an inhaler met its goals in a phase 2 trial. The company has been making slow but steady progress with ensifentrine and finally… Read More »Boost for Verona Pharma after trial win with inhaled COPD drug
In a recent interview with PharmaShots, Jonas Duss, US CEO and Co-Founder at Kaia Health shared his views on the Kaia Health’s COPD Pulmonary Rehabilitation App and their collaboration with Chiesi Group to commercialize the app in EU. Shots: Kaia Health signs an exclusive agreement… Read More »ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App
In a recent interview with PharmaShots, Dr. Riju Ray, MD, PhD, Senior Medical Lead at GSK, leading US medical affairs across asthma and COPD shared his views on how community-based pulmonologists are improving COPD management and education among referring PCPs. Shots: Pulmonologists identified 12 strong… Read More »ViewPoints Interview: GSK’s Dr. Riju Ray Shares Insights on the Role of Community-Based Pulmonologists in Improving COPD Management Among PCPs
What You Should Know: – Wolters Kluwer, Health launches new Alexa skill, Emmi Care Plan to keep patients engaged with their care team at home following discharge from the hospital. – Using a natural dialogue that automatically adjusts to patient responses, customers can engage with… Read More »Wolters Kluwer Launches Alexa Skill to Keep Patients Engaged With Their Care Team at Home
In the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Propeller Health about how digital technologies are revolutionising the field of respiratory medicine. The post Health Innovators: David Van Sickle on digital innovation in respiratory medicine appeared… Read More »Health Innovators: David Van Sickle on digital innovation in respiratory medicine
What You Should Know: – Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management. – Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize… Read More »Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health
What You Should Know: – Mayo Clinic announced a collaboration with Vocalis Health to to research and develop new voice-based tools for screening, detecting and monitoring patient health, beginning with a study to identify vocal biomarkers to detect pulmonary hypertension (PH). – The clinical validation… Read More »Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection
Eric Tran, Tulane School of Medicine Donald Voltz, MD, Aultman Hospital The COVID-19 virus is ravaging the planet at a scale not seen since the infamous Spanish Flu of the early 1900s, inflicting immense devastation as the U.S. loses more than 200,000 lives and counting.… Read More »Rural Hospital Execs Can Beat COVID-19 By Shifting From Reactive to Proactive Care
What You Should Know: – Today, Blue Cross and Blue Shield of North Carolina partners with Carrot Inc. and Virta Health to help address two of the largest ongoing health issues facing Americans today – smoking and type 2 diabetes. – Virta and Carrot’s programs… Read More »Blue Cross NC Launches No-Cost Virtual Programs to Quit Smoking and Reverse Diabetes
Shots: The CHMP’s positive opinion is based on P-III ETHOS & KRONOS studies, which are a part of AstraZeneca’s P-III ATHENA program assessing Trixeo Aerosphere in 15500+ patients globally across 11 trials P-III ETHOS study results reported that triple-combination therapy showed a reduction in the… Read More »AstraZeneca’s Trixeo Aerosphere Receives CHMP’s Recommendation for Approval to Treat COPD
AireHealth, which makes portable nebulizers for patients with respiratory conditions, plans to launch its first connected product next year.
Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug companies repurposing their medicines to fight the pandemic. Based in the UK and US, Verona is due to start a phase 3 trial of ensifentrine in chronic… Read More »Verona Pharma to trial lung drug ensifentrine for COVID-19
What You Should Know: – Innovaccer has recently partnered with CareSignal to address healthcare’s urgent need amidst the COVID-19 pandemic: to create and maintain solid, clinically actionable relationships with patients in a new set of predominantly virtual care. – CareSignal offers evidence-based end-to-end support services… Read More »Innovaccer, CareSignal Partner to Enable Deviceless Remote Patient Monitoring
Shots: The approval is based on P-III ETHOS study assessing of Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) vs dual therapies [Bevespi Aerosphere (glycopyrronium/formoterol fumarate) and PT009 (budesonide/formoterol fumarate)] with mod. to sev. COPD and a history of exacerbation(s) in the previous year The P-III ETHOS study demonstrated… Read More »AstraZeneca’s Breztri Aerosphere Receives the US FDA’s Approval for the Maintenance Treatment of COPD
AstraZeneca’s triple therapy for chronic obstructive pulmonary disease (COPD), Breztri Aerosphere (budesonide+glycopyrrolate+formoterol fumarate), has been approved in the US following a rejection last year. Approval follows a rejection by the FDA in October last year after the FDA refused to grant a licence based on… Read More »AZ’s COPD triple therapy approved in the US
Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the system conveys information to patients, who can use the product branded as ProAir Digihaler (albuterol sulfate) for patients… Read More »Teva launches digital asthma and COPD rescue inhaler in US
What You Should Know: – Propeller Health announced it will co-package a new asthma medication from Novartis, which was approved by the European Commission this week for use in the EU. – Enerzair® Breezhaler® plus Propeller Health sensor is the first asthma medication to be… Read More »Propeller Health, Novartis Co-Package Asthma Medication in Europe for Prescription
<div class="right-align"> <a class="btn btn-blue _gt" data-category="Hospital" data-action="Click-Button" data-label="Blog-Reducing Respiratory Failure Readmissions While COPD Is on the Rise" href="https://www.kindredhealthcare.com/docs/default-source/default-document-library/kindred-respiratory-failure-whitepaper.pdf?sfvrsn=74f58dea_2" title="Reducing Respiratory Failure Readmissions While COPD Is on the Rise" target="_blank">Download this article as a PDF</a></div> <br /> <p>Diagnoses of Chronic Obstructive Pulmonary Disease (COPD) have… Read More »Reducing Respiratory Failure Readmissions While COPD Is on the Rise